Back

SoMAS: Finding somatic mutations associated with alternative splicing in human cancers

Tan, H.; Gotea, V.; Seidel, N. E.; Holland, D. O.; Fedkenheuer, K.; Jaiswal, S. K.; Bang-Christensen, S.; Elnitski, L. L.

2023-07-07 cancer biology
10.1101/2023.07.06.547933 bioRxiv
Show abstract

Aberrant alternative splicing is prevalent in cancer and affects most cancer hallmarks involving proliferation, angiogenesis, and invasion. Somatic point mutations can exert their cancer-driving functions via splicing disruption. We propose "SoMAS" (Somatic Mutation associated with Alternative Splicing), an efficient computational pipeline based on principal component analysis techniques, to explore the role of somatic mutations in shaping the landscape of alternative splicing via both cis- and trans-acting mechanisms. Applying SoMAS to 33 cancer types consisting of 9,738 tumor samples in The Cancer Genome Atlas, we identified 908 somatically mutated genes significantly associated with altered isoform expression in three or more cancer types. These genes include many well-known oncogenes/suppressor genes, RNA binding protein and splicing factor genes with both biological and clinical significance. Many of our identified SoMAS genes were corroborated to affect gene splicing by independent cohorts and/or methodologies. With SoMAS, we for the first time demonstrate the potential network of somatic mutations associated with the overall splicing profiles of cancer transcriptomes, bridging the genetic and epigenetic regulation of human tumorigenesis in an innovative way.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Genome Biology
○ 637 papers in training set
Top 0.9%
11.6%
Similar papers in this journal
2
Nature Communications
○ 5641 papers in training set
Top 22%
7.7%
Similar papers in this journal
3
Nucleic Acids Research
◐ 1281 papers in training set
Top 2%
7.7%
Similar papers in this journal
4
eLife
● 5828 papers in training set
Top 18%
6.6%
Similar papers in this journal
5
Genomics, Proteomics & Bioinformatics
188 papers in training set
Top 0.3%
6.1%
6
Genome Research
● 468 papers in training set
Top 1.0%
6.1%
7
Genome Medicine
○ 183 papers in training set
Top 0.5%
6.1%
50% of probability mass above
8
Cancer Research
● 130 papers in training set
Top 1.0%
3.9%
9
Cell Reports
○ 1498 papers in training set
Top 12%
3.2%
10
Communications Biology
○ 993 papers in training set
Top 6%
3.1%
11
Oncogene
○ 85 papers in training set
Top 0.7%
3.1%
12
NAR Cancer
◐ 37 papers in training set
Top 0.1%
3.1%
13
Cell Genomics
○ 172 papers in training set
Top 2%
1.9%
14
PLOS Genetics
● 862 papers in training set
Top 7%
1.6%
15
Science Advances
● 1243 papers in training set
Top 23%
1.4%
16
Molecular Cancer
○ 16 papers in training set
Top 0.2%
1.3%
17
npj Genomic Medicine
○ 36 papers in training set
Top 0.5%
1.3%
18
Molecular Cancer Research
● 49 papers in training set
Top 1%
1.1%
19
Cancer Letters
○ 35 papers in training set
Top 0.9%
1.1%
20
Cancers
○ 213 papers in training set
Top 4%
1.0%
21
PLOS Computational Biology
● 1863 papers in training set
Top 18%
1.0%
22
Clinical and Translational Medicine
○ 31 papers in training set
Top 0.7%
1.0%
23
iScience
○ 1154 papers in training set
Top 33%
1.0%
24
Cancer Research Communications
● 51 papers in training set
Top 2%
0.8%
25
Briefings in Bioinformatics
◐ 354 papers in training set
Top 7%
0.8%
26
Scientific Reports
○ 3612 papers in training set
Top 74%
0.8%
27
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 42%
0.8%
28
Molecular Oncology
○ 55 papers in training set
Top 1%
0.8%
29
Advanced Science
○ 286 papers in training set
Top 12%
0.6%
30
PLOS ONE
● 5266 papers in training set
Top 63%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.